Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 3
2017 3
2018 9
2019 10
2020 15
2021 11
2022 6
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer.
Najminejad Z, Dehghani F, Mirzaei Y, Mer AH, Saghi SA, Abdolvahab MH, Bagheri N, Meyfour A, Jafari A, Jahandideh S, Gharibi T, Amirkhani Z, Delam H, Mashatan N, Shahsavarani H, Abdollahpour-Alitappeh M. Najminejad Z, et al. Among authors: abdollahpour alitappeh m. Mol Ther. 2023 Jul 5;31(7):1874-1903. doi: 10.1016/j.ymthe.2023.03.019. Epub 2023 Mar 22. Mol Ther. 2023. PMID: 36950736 Review.
Targeting STAT3 in cancer and autoimmune diseases.
Gharibi T, Babaloo Z, Hosseini A, Abdollahpour-Alitappeh M, Hashemi V, Marofi F, Nejati K, Baradaran B. Gharibi T, et al. Among authors: abdollahpour alitappeh m. Eur J Pharmacol. 2020 Jul 5;878:173107. doi: 10.1016/j.ejphar.2020.173107. Epub 2020 Apr 9. Eur J Pharmacol. 2020. PMID: 32278856 Review.
How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment?
Yaghoubi S, Najminejad H, Dabaghian M, Karimi MH, Abdollahpour-Alitappeh M, Rad F, Mahi-Birjand M, Mohammadi S, Mohseni F, Sobhani Lari M, Teymouri GH, Rigi Yousofabadi E, Salmani A, Bagheri N. Yaghoubi S, et al. Among authors: abdollahpour alitappeh m. IUBMB Life. 2020 Jul;72(7):1286-1305. doi: 10.1002/iub.2275. Epub 2020 Mar 20. IUBMB Life. 2020. PMID: 32196941 Free article. Review.
Regulatory T and T helper 17 cells: Their roles in preeclampsia.
Hosseini A, Dolati S, Hashemi V, Abdollahpour-Alitappeh M, Yousefi M. Hosseini A, et al. Among authors: abdollahpour alitappeh m. J Cell Physiol. 2018 Sep;233(9):6561-6573. doi: 10.1002/jcp.26604. Epub 2018 Apr 16. J Cell Physiol. 2018. PMID: 29663372 Review.
Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technology.
Sadeqi Nezhad M, Yazdanifar M, Abdollahpour-Alitappeh M, Sattari A, Seifalian A, Bagheri N. Sadeqi Nezhad M, et al. Among authors: abdollahpour alitappeh m. Biotechnol Bioeng. 2021 Oct;118(10):3691-3705. doi: 10.1002/bit.27882. Epub 2021 Jul 21. Biotechnol Bioeng. 2021. PMID: 34241908 Review.
Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes.
Abdollahpour-Alitappeh M, Lotfinia M, Gharibi T, Mardaneh J, Farhadihosseinabadi B, Larki P, Faghfourian B, Sepehr KS, Abbaszadeh-Goudarzi K, Abbaszadeh-Goudarzi G, Johari B, Zali MR, Bagheri N. Abdollahpour-Alitappeh M, et al. J Cell Physiol. 2019 May;234(5):5628-5642. doi: 10.1002/jcp.27419. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30478951 Review.
Emerging roles of exosomal miRNAs in breast cancer drug resistance.
Najminejad H, Kalantar SM, Abdollahpour-Alitappeh M, Karimi MH, Seifalian AM, Gholipourmalekabadi M, Sheikhha MH. Najminejad H, et al. Among authors: abdollahpour alitappeh m. IUBMB Life. 2019 Nov;71(11):1672-1684. doi: 10.1002/iub.2116. Epub 2019 Jul 19. IUBMB Life. 2019. PMID: 31322822 Free article. Review.
64 results